Greenwich Lifesciences Inc (GLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 19,448 | 17,637 | 9,328 | 8,040 | 4,598 |
| Operating Income | -19,448 | -17,637 | -9,328 | -8,040 | -4,598 |
| Other Income | 90 | 223 | 436 | 215 | 27 |
| Pre-tax Income | -19,358 | -17,414 | -8,892 | -7,825 | -4,571 |
| Net Income Continuous | -19,358 | -17,414 | -8,892 | -7,825 | -4,571 |
| Net Income | $-19,358 | $-17,414 | $-8,892 | $-7,825 | $-4,571 |
| EPS Basic Total Ops | -1.43 | -1.34 | -0.69 | -0.61 | -0.35 |
| EPS Basic Continuous Ops | -1.43 | -1.34 | -0.69 | -0.61 | -0.35 |
| EPS Diluted Total Ops | -1.43 | -1.34 | -0.69 | -0.61 | -0.35 |
| EPS Diluted Continuous Ops | -1.43 | -1.34 | -0.69 | -0.61 | -0.35 |
| EPS Diluted Before Non-Recurring Items | -1.43 | -1.21 | -0.69 | -0.61 | -0.35 |
| EBITDA(a) | $-19,446 | $-17,634 | $-9,324 | $-8,037 | $-4,594 |